Blog

Using AI to Prepare for a Clinical Trial Conversation After a Medulloblastoma Diagnosis

In my role as a Research Support Coordinator, with a background in nursing and clinical trials, much of my work has focused on helping make complex clinical information more accessible. One of the most consistent challenges I see is how much information families are given early in the process, and how complex that information can be. In diseases like medulloblastoma, conversations about treatment and clinical trials often happen quickly, and they involve terminology and details that are difficul

Targeting a Key Vulnerability in Medulloblastoma

I recently spoke with Dr. Rao at the University of Texas Health Science Center at San Antonio about his 2024 research project funded by The Cure Starts Now. His work focuses on medulloblastoma, the most common cancerous brain tumor in children, and explores a new way to make these tumors more responsive to treatment. Before diving into his findings, Dr. Rao shard something many families already know. While progress has been made, there is still a long way to go. Why New Approaches Matter Som

Advancing Therapeutic Strategies for Medulloblastoma: Insights from Dr. Luiz Penalva and Dr. Andrew Beekman

Dr. Luiz Penalva of UT Health Science Center and Dr. Andrew Beekman of the University of East Anglia presented groundbreaking research focused on ribosomal RNA (rRNA) modification and its role in the progression of medulloblastoma, one of the most aggressive pediatric brain tumors. Their collaborative work explores how targeting fundamental cellular mechanisms may open new therapeutic avenues. Ribosome Biogenesis and Medulloblastoma Dr. Penalva explained that cancer cells, including medullob